
Deals & Capital Markets
Sanofi Pays $2.2 Billion for Dynavax in Bet on Adult Vaccines Amid Policy Uncertainty
Dec 25, 2025
You're signed outSign in or to get full access.
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
Research analysts covering DYNAVAX TECHNOLOGIES.